<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

GW 843682X

產(chǎn)品貨號

Axon 1131 CAS [660868-91-7] MF C22H18F3N3O4SMW 477.46 Purity: 99% Soluble in DMSO Description Polo-like kinase (PLK) inhibitor; selective at PLK1 (IC50: 2 nM)?and PLK3 (IC50: 9 nM) References Certificates Categories Extra info EF Johnson et al.?Pharmacological and Functional Comparison of the Polo-like Kinase Family: Insight into Inhibitor and Substrate Specificity.?Biochemistry 2007, 46(33), 9558. ? T Lansing et al.?In vitro?biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Mol.?Cancer Ther.?2007,?6, 450-459. Certificate of Analysis Material Safety Data Sheet Cell Cycle Regulation Cell Signaling & Oncology EC 2.7.11.21 PLK PLK1 and PLK3 inhibitor Chemical name 5-(5,6-Dimethoxy-benzoimidazol-1-yl-3-(2-trifluoromethyl-benzyloxy)-thiophene-2-carboxylic acid amide Parent CAS No. [660868-91-7] Order Size Unit Price Stock 5 mg €75.00 In Stock

產(chǎn)品價格

現(xiàn)貨詢價，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

GW 843682X

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 1131

CAS [660868-91-7]

MF C22H18F3N3O4S
MW 477.46

Purity: 99%
Soluble in DMSO

GW 843682X

Description

Polo-like kinase (PLK) inhibitor; selective at PLK1 (IC50: 2 nM)?and PLK3 (IC50: 9 nM)

EF Johnson et al.?Pharmacological and Functional Comparison of the Polo-like Kinase Family: Insight into Inhibitor and Substrate Specificity.?Biochemistry 2007, 46(33), 9558.

T Lansing et al.?In vitro?biological activity of a novel small-molecule inhibitor of polo-like kinase 1. Mol.?Cancer Ther.?2007,?6, 450-459.

Certificate of Analysis
Material Safety Data Sheet

Cell Cycle Regulation Cell Signaling & Oncology EC 2.7.11.21 PLK

PLK1 and PLK3 inhibitor

Chemical name

5-(5,6-Dimethoxy-benzoimidazol-1-yl-3-(2-trifluoromethyl-benzyloxy)-thiophene-2-carboxylic acid amide

Parent CAS No.

[660868-91-7]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>